HUM240712P357500
- 0.20
- -0.25-55.56%
Humana Newsroom
Update: US FTC Report Says Pharmacy Benefit Managers Contribute to Higher Drug Costs
(Updates to add comment from United Health's Optum in the seventh paragraph.)CVS Health's (CVS) Caremark, UnitedHealth Group's (UNH) Optum, and Cigna Group's (CI) Express Scripts are among the top
FTC Investigation Uncovers Anti-Competitive Practices By Handful Of Pharmacy Benefit Managers, Including CVS Health, UnitedHealth
The U.S. Federal Trade Commission (FTC) has highlighted significant concerns regarding consolidating pharmacies and health insurance companies, focusing on the influence of a few dominant pharmacy
US FTC Report Says Pharmacy Benefit Managers Contribute to Higher Drug Costs
CVS Health's (CVS) Caremark, UnitedHealth Group's (UNH) Optum, and Cigna Group's (CI) Express Scripts are among the top six pharmacy middlemen that contribute to higher drug costs and challenge the
Pharma Middlemen Benefit at the Expense of Patients: FTC
Here's Why Appleseed Fund Added Humana (HUM) on Dip
USA government unhappy with high drug prices, these three American healthcare giants have become “regulatory targets”.
According to Zhìtōng Cáijīng, the US Federal Trade Commission (FTC) stated on Tuesday that the integration of pharmacies and medical insurance companies after years of mergers has led to a few pharmacy benefit management companies exerting too much influence on prescription drug prices. The antitrust efforts of US regulators has focused on several large pharmacy benefit management companies, with the three largest in the US being Optum of UnitedHealth (UNH.US), CVS Caremark of CVS Health (CVS.US), and Express Scripts of The Cigna Group (CI.US). Pharmaceutical benefits.
RBC Raises Price Target on Humana to $385 From $353, Outperform Rating Kept
Humana (HUM) has an average outperform rating and a price target range of $326 to $473, according to analysts polled by Capital IQ.Price: 368.50, Change: -1.93, Percent Change: -0.52
Medicare Advantage Linked to Fattest Gross Profits in Insurance: Report
What Trump 2.0 or Biden 2.0 Could Mean for the Stock Market
President Biden is publicly showing no signs of stepping back and held a virtual meeting with governors on Wednesday to try to reassure them he's up to the job.
One Humana Insider Raised Stake By 34% In Previous Year
Mizhuo's Top Picks in Healthcare for July
Wake up and Smell the Independence... and All Time Highs | Wall Street Today
The U.S. independence day began with fresh highs from both the
Fresh Highs for a Short Day | Herd on Wall Street
Morning traders! The short trading day of July 3rd began with a fresh all-time high for the
Walmart Explores Sale Of Closed Health Clinics To Recoup Investments: Report
Walmart Inc. (NYSE:WMT) has reportedly entered discussions with prospective buyers to offload its recently closed medical clinics.In April, Walmart announced the shutdown of all 51 of its health clini
Walmart Exploring Possible Sale of Healthcare Centers: Report
Walmart (NYSE:WMT) has reportedly held talks with parties such as Humana (HUM) over a possible sale of its financially troubled healthcare centers business.
Sector Update: Health Care Stocks Softer Late Afternoon
Health care stocks were retreating late Tuesday afternoon, with the NYSE Health Care Index down 0.5% and the Health Care Select Sector SPDR Fund (XLV) decreasing 0.4%. The iShares Biotechnology ETF (I
Market Chatter: Walmart in Talks to Sell Medical Clinics
Walmart (WMT) has discussed potential take over of its Walmart Health clinics that it has already started to close with potential buyers, including Humana (HUM), Fortune reported Tuesday, citing multiple sources familiar with the situation.
2024 Mid-Year Outlook | Wall Street Forecasts for U.S. Equities Amidst a Volatile Macroeconomic Landscape
Wall Street Forecasts for U.S. Equities Amidst a Volatile Macroeconomic Landscape.
Will Trump's Debate Advantage Give Biotech and Healthcare Stocks a Lift?
As the dust settles on the latest presidential debate, market analysts are scrutinizing the implications of a potential shift in the political landscape.
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report